| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5596842 | The Annals of Thoracic Surgery | 2017 | 7 Pages |
Abstract
Neoadjuvant chemotherapy followed by radical surgery is a safe and effective strategy in patients with primary right-side heart sarcoma. This multimodality treatment enhances resectability (R0 resection) that translates into improved patient survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Walid K. MD, Basel MD, Oz M. MD, Odeaa MD, Vinod MD, Robert MD, Jean-Bernard MD, Monika J. MD, Shanda H. MD, Brian A. MD, Michael J. MD,